Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 2 | $5,000,680 |
Sells | 13 | $795,017 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Jun 2024 16:31 | ALLO | Allogene Therapeutics Inc | MESSEMER DEBORAH M. | Director | 18 Jun 2024 | Sale | 18,641 | 2.2793 | 42,488 | D |
03 Jun 2024 16:09 | ALLO | Allogene Therapeutics Inc | HUMER FRANZ B | Director | 30 May 2024 | Sale | 11,200 | 2.3376 | 26,181 | D |
20 May 2024 21:33 | ALLO | Allogene Therapeutics Inc | BELLDEGRUN ARIE | Director | 16 May 2024 | Purchase | 1,724,137 | 2.9 | 4,999,997 | I |
06 Mar 2024 21:52 | ALLO | Allogene Therapeutics Inc | PARKER GEOFFREY M. | CHIEF FINANCIAL OFFICER | 30 Jan 2024 | Purchase | 190 | 3.595 | 683 | D |
20 Dec 2023 16:26 | ALLO | Allogene Therapeutics Inc | MESSEMER DEBORAH M. | Director | 18 Dec 2023 | Sale | 18,640 | 2.6994 | 50,317 | D |
09 Aug 2023 16:07 | ALLO | Allogene Therapeutics Inc | MAYO STEPHEN | Director | 07 Aug 2023 | Sale | 10,000 | 4.2855 | 42,855 | D |
14 Feb 2023 17:10 | ALLO | Allogene Therapeutics Inc | BHAVNAGRI VEER | General Counsel | 13 Feb 2023 | Sale | 3,000 | 6.85 | 20,550 | D |
18 Jan 2023 18:10 | ALLO | Allogene Therapeutics Inc | BHAVNAGRI VEER | General Counsel | 17 Jan 2023 | Sale | 3,000 | 7.04 | 21,120 | D |
19 Dec 2022 16:29 | ALLO | Allogene Therapeutics Inc | BHAVNAGRI VEER | General Counsel | 15 Dec 2022 | Sale | 5,602 | 7.5306 | 42,186 | D |
15 Aug 2022 17:40 | ALLO | Allogene Therapeutics Inc | WITTE OWEN N. | Director | 12 Aug 2022 | Sale | 5,000 | 17.25 | 86,250 | D |
15 Aug 2022 17:40 | ALLO | Allogene Therapeutics Inc | WITTE OWEN N. | Director | 11 Aug 2022 | Sale | 10,000 | 16.5 | 165,000 | D |
15 Aug 2022 17:12 | ALLO | Allogene Therapeutics Inc | WITTE OWEN N. | Director | 12 Aug 2022 | Sale | 5,000 | 17.25 | 86,250 | D |
15 Aug 2022 17:12 | ALLO | Allogene Therapeutics Inc | WITTE OWEN N. | Director | 11 Aug 2022 | Sale | 10,000 | 16.5 | 165,000 | D |
02 Aug 2022 17:40 | ALLO | Allogene Therapeutics Inc | AMADO RAFAEL | EVP of R&D and CMO | 02 Aug 2022 | Sale | 2,000 | 11.97 | 23,940 | D |
06 Jul 2022 16:16 | ALLO | Allogene Therapeutics Inc | AMADO RAFAEL | EVP of R&D and CMO | 05 Jul 2022 | Sale | 2,000 | 11.44 | 22,880 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)